One Month After Resigning from Sequenom, Schuh Named CEO of Arcturus

Toni Schuh will serve as the new CEO of Arcturus, the company said this week, nearly one month after Schuh stepped down as CEO of Sequenom.

Arcturus Bioscience, a privately held firm based in Mountain View, Calif., said that Schuh will also be elected to its board of directors.

Schuh succeeds former CEO and founder Thomas Baer, who resigned in late 2004 to serve as a consulting professor in the Applied Physics department at Stanford University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.